Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susan H. Camacho"'
Autor:
David A. Bellnier, Richard T. Cheney, Joseph A. Spernyak, Richard Mazurchuk, Allan R. Oseroff, Susan H. Camacho, Mukund Seshadri
Publikováno v:
Clinical Cancer Research. 11:4241-4250
Purpose: Photodynamic therapy (PDT) is a clinically approved treatment for a variety of solid malignancies. 5,6-Dimethylxanthenone-4-acetic acid (DMXAA) is a potent vascular targeting agent that has been shown to be effective against a variety of exp
Autor:
Guosheng Wang, David A. Bellnier, Michael A. J. Rodgers, Joseph R. Missert, Thomas J. Dougherty, Susan H. Camacho, William R. Potter, Barbara W. Henderson, Ravindra K. Pandey, Gang Zheng
Publikováno v:
Journal of Medicinal Chemistry. 44:1540-1559
Starting from methylpheophorbide-a, a homologous series of purpurinimides containing alkyl substituents at two different positions [as 3-(1(1)-O-alkyl) and 13(2)-N-alkyl] were synthesized. These compounds with variable lipophilicity (log P 5.32-16.44
Publikováno v:
Photochemistry and Photobiology. 70:630-636
Ideal photosensitizers have long-wavelength absorption and strong tumor selectivity with rapid clearance from normal tissues. The telluroselenopyrylium dye 1 that absorbs light at 795 nm (epsilon = 285,000 M-1 cm-1) has a novel property that enhances
Publikováno v:
Photochemistry and Photobiology. 69:222-225
The role of the irradiation site in the induction of suppression of the contact hypersensitivity (CHS) response following photodynamic therapy (PDT) was examined in a murine model. Laser irradiation on the flanks of nontumor-bearing Photofrin-injecte
Autor:
Susan H. Camacho, Petr Starostik, Minoo Battiwalla, Mehmet Hepgur, Paul K. Wallace, Dalin Pan, Manmeet S. Ahluwalia, Philip L. McCarthy
Publikováno v:
Cytometry. Part B, Clinical cytometry. 78(5)
Background: Glycosyl-phosphatidylinositol (GPI)-negative blood cells are diagnostic for Paroxysmal Nocturnal Hemoglobinuria (PNH). Marrow failure states are often associated with GPI-negative cell populations. Quantification of small clonal populatio
Publikováno v:
Cancer research. 63(22)
DMXAA (5,6-dimethylxanthenone-4-acetic acid) is an antivascular agent that exerts its antitumor effect at least partly through the induction of tumor necrosis factor (TNF)-alpha. Photodynamic therapy (PDT), the activation of a photoreactive drug in t